Potassium and Ayvakit drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Ayvakit (avapritinib). Common drug interactions include swelling among females and pruritus among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Ayvakit. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,148 Potassium users. Check the latest studies of Potassium.

What is Ayvakit?

Ayvakit has active ingredients of avapritinib. eHealthMe is studying from 7,362 Ayvakit users. Check the latest studies of Ayvakit.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

19 people who take Potassium and Ayvakit together, and have interactions are studied.

Potassium and Ayvakit drug interactions.

What are the common drug interactions of Potassium and Ayvakit, by gender? *:

female:

  1. Swelling
  2. Depression
  3. Fatigue (feeling of tiredness)
  4. Agitation (state of anxiety or nervous excitement)
  5. Anxiety
  6. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  7. Dark circles under eyes
  8. Depressed mood
  9. Drug ineffective
  10. Dry eye (lack of adequate tears)

male:

  1. Pruritus (severe itching of the skin)
  2. Dizziness
  3. Leukaemia (blood or bone marrow cancer)
  4. Platelet count decreased
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Photosensitivity reaction
  7. Rash
  8. Rash macular (small, flat red spots)
  9. Rash papular (redness with papule)
  10. Amblyopia (lazy eye)

What are the common drug interactions of Potassium and Ayvakit, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Blood calcium decreased
  3. Blood magnesium decreased
  4. Photosensitivity reaction
  5. Pruritus (severe itching of the skin)
  6. Rash
  7. Rash macular (small, flat red spots)
  8. Rash papular (redness with papule)
  9. Dizziness
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Swelling
  2. Agitation (state of anxiety or nervous excitement)
  3. Anxiety
  4. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  5. Dark circles under eyes
  6. Depressed mood
  7. Depression
  8. Drug ineffective
  9. Dry eye (lack of adequate tears)
  10. Eye irritation

60+:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Platelet count decreased
  3. Hypersomnia (excessive daytime sleepiness (eds))
  4. Peripheral swelling
  5. Tryptase increased
  6. Haemorrhage (bleeding)
  7. Dizziness
  8. Dry eye (lack of adequate tears)
  9. Eye discharge
  10. Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

  1. Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 8 people, 42.11%
  2. Mastocytic Leukaemia (presence of large numbers of tissue mast cells in the peripheral blood without skin lesions): 6 people, 31.58%
  3. Gastrointestinal Stromal Tumor: 6 people, 31.58%
  4. Vitamin B12 Deficiency: 2 people, 10.53%
  5. Rickets (softening of bones): 2 people, 10.53%
  6. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 2 people, 10.53%
  7. Haematopoietic Neoplasm (clonal disorders of blood cells cause abnormal mass of tissue cell): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Ayvakit?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium and Ayvakit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ayvakit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ayvakit and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium and avapritinib (the active ingredients of Potassium and Ayvakit, respectively), and Potassium and Ayvakit (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: